BRPI0411369A - regulagem da expressão gênica da matriz metaloproteinase usando sinais elétricos e eletromagnéticos especìficos e seletivos - Google Patents

regulagem da expressão gênica da matriz metaloproteinase usando sinais elétricos e eletromagnéticos especìficos e seletivos

Info

Publication number
BRPI0411369A
BRPI0411369A BRPI0411369-1A BRPI0411369A BRPI0411369A BR PI0411369 A BRPI0411369 A BR PI0411369A BR PI0411369 A BRPI0411369 A BR PI0411369A BR PI0411369 A BRPI0411369 A BR PI0411369A
Authority
BR
Brazil
Prior art keywords
gene expression
specific
electromagnetic signals
selective
regulation
Prior art date
Application number
BRPI0411369-1A
Other languages
English (en)
Inventor
Carl T Brighton
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of BRPI0411369A publication Critical patent/BRPI0411369A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61HPHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/40Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Treatment Devices (AREA)

Abstract

"REGULAGEM DA EXPRESSãO GêNICA DA MATRIZ METALOPROTEINASE USANDO SINAIS ELéTRICOS E ELETROMAGNéTICOS ESPECìFICOS E SELETIVOS". Métodos e aparelhos para a regulagem da expressão gênica da matriz metaloproteinase em células cartilaginosas por meio da aplicação de campos gerados por sinais elétricos e eletromagnéticos específicos e seletivos no tratamento da cartilagem articular doente ou ferida. Expressão gênica refere-se à regulagem para cima ou regulagem para baixo do processo pelo qual porções específicas (genes) do genoma humano (DNA) são transcritos em mRNA e subseqüentemente traduzidos em proteína. São fornecidos métodos e aparelhos para o tratamento direcionado ao alvo do tecido cartilaginoso ferido ou doente, incluindo a geração de sinais elétricos e eletromagnéticos específicos e seletivos que geram campos otimizados para a redução da expressão gênica da matriz metaloproteinase e a exposição do tecido cartilaginoso aos campos gerados por sinais específicos e seletivos, de modo a regular a expressão gênica da matriz metaloproteinase no referido tecido cartilaginoso. Os métodos e aparelhos resultantes são úteis para o tratamento direcionado ao alvo da osteoartrite, artrite reumatóide, ferimentos da cartilagem, defeitos da cartilagem e metástase de tumor.
BRPI0411369-1A 2003-06-13 2004-06-14 regulagem da expressão gênica da matriz metaloproteinase usando sinais elétricos e eletromagnéticos especìficos e seletivos BRPI0411369A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/461,188 US7429471B2 (en) 2000-02-23 2003-06-13 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
PCT/US2004/019137 WO2004112708A2 (en) 2003-06-13 2004-06-14 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals

Publications (1)

Publication Number Publication Date
BRPI0411369A true BRPI0411369A (pt) 2006-08-01

Family

ID=33538972

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0411369-1A BRPI0411369A (pt) 2003-06-13 2004-06-14 regulagem da expressão gênica da matriz metaloproteinase usando sinais elétricos e eletromagnéticos especìficos e seletivos

Country Status (14)

Country Link
US (1) US7429471B2 (pt)
EP (1) EP1643953A4 (pt)
JP (1) JP2007502693A (pt)
KR (1) KR100856964B1 (pt)
CN (1) CN1822807A (pt)
AU (1) AU2004249202A1 (pt)
BR (1) BRPI0411369A (pt)
CA (1) CA2529374C (pt)
CR (1) CR8145A (pt)
EG (1) EG24170A (pt)
IL (1) IL172508A0 (pt)
MX (1) MXPA05013493A (pt)
NO (1) NO20060193L (pt)
WO (1) WO2004112708A2 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429471B2 (en) 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7022506B2 (en) * 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US8313908B2 (en) 2000-02-23 2012-11-20 The Trustees Of The University Of Pennsylvania Regulation of stem cell gene production with specific and selective electric and electromagnetic fields
US7981611B2 (en) * 2000-02-23 2011-07-19 The Trustees Of The University Of Pennsylvania Regulation of fibroblastic growth factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields
US7465566B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7465546B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7374916B2 (en) 2000-02-23 2008-05-20 The Trustees Of The University Of Pennsylvania Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals
US7215995B2 (en) * 2003-11-14 2007-05-08 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis and cartilage disease, defects, and injuries in the human hip
US9427598B2 (en) 2010-10-01 2016-08-30 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic treatment of head, cerebral and neural injury in animals and humans
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
JP4801802B2 (ja) * 2004-01-12 2011-10-26 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 特定の選択的な電気信号および電磁信号によって生成される電場の印加を介して骨細胞における骨形成タンパク質(bmp)遺伝子発現を上方制御するシステムおよび方法
KR20070024533A (ko) 2004-04-19 2007-03-02 아이비비 테크놀로지스, 아이엔씨. 전자기 치료 장치 및 방법
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US20090018613A1 (en) * 2006-08-02 2009-01-15 Genestim, Llc Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
EP2703001A1 (en) * 2012-08-26 2014-03-05 XAX Kft. Tumor vaccination
US9320913B2 (en) 2014-04-16 2016-04-26 Rio Grande Neurosciences, Inc. Two-part pulsed electromagnetic field applicator for application of therapeutic energy
WO2016129846A1 (ko) * 2015-02-12 2016-08-18 최규환 토양 미생물을 이용한 음식물 쓰레기 발효 장치및 축분 비료화 장치, 이에 적합한 바이오필드 발생 장치, 이에 적합한 미생물 전지 및 이에 적합한 미생물 콘덴서
US10806942B2 (en) 2016-11-10 2020-10-20 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506674A (en) 1981-11-10 1985-03-26 Trustees Of The University Of Pennsylvania Method of stimulating osteogenesis with distributed port cathode
US4430999A (en) 1981-11-10 1984-02-14 Trustees Of The University Of Pennsylvania Osteogenesis stimulating cathode assembly for use with an internal fixation device
US4442846A (en) 1981-11-10 1984-04-17 University Of Pennsylvania Distributed port bone-piercing cathode for electrically stimulated osteogenesis
US4509520A (en) 1982-02-22 1985-04-09 Biolectron, Inc. Electrical stimulating apparatus
US4549547A (en) 1982-07-27 1985-10-29 Trustees Of The University Of Pennsylvania Implantable bone growth stimulator
US4467809A (en) * 1982-09-17 1984-08-28 Biolectron, Inc. Method for non-invasive electrical stimulation of epiphyseal plate growth
US4487834A (en) 1982-09-17 1984-12-11 Biolectron, Inc. Electrical stimulation of articular chondrocytes
US4467808A (en) 1982-09-17 1984-08-28 Biolectron, Inc. Method for preventing and treating osteoporosis in a living body by using electrical stimulation non-invasively
US5269746A (en) 1982-12-20 1993-12-14 Jacobson Jerry I Therapeutic treatment of mammals for epilepsy and Parkinson's disease
US4535775A (en) 1983-02-10 1985-08-20 Biolectron, Inc. Method for treatment of non-union bone fractures by non-invasive electrical stimulation
IT1159024B (it) 1983-06-02 1987-02-25 Ruggero Cadossi Metodo e dispositivo per il trattamento di tessuti e cellule viventi mediante campi elettromagnetici pulsanti
US4600010A (en) * 1984-10-04 1986-07-15 Biolectron, Inc. Electric stimulator and test instrument therefor
US4998532A (en) 1986-05-23 1991-03-12 Lti Biomedical, Inc. Portable electro-therapy system
US5014699A (en) 1986-05-23 1991-05-14 Trustees Of The University Of Pennsylvania Electromagnetic method and apparatus for healing living tissue
US6120502A (en) 1988-06-13 2000-09-19 Michelson; Gary Karlin Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis
CA2004192A1 (en) * 1988-11-30 1990-05-31 Jerry I. Jacobson Therapeutic treatment of mammals
US5038797A (en) 1990-02-20 1991-08-13 Romaine, Incorporated Electrical stimulation treatment device and method of use
US5273033A (en) 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5338286A (en) 1992-12-08 1994-08-16 Electro-Biology, Inc. Electromagnetic bioresponse by selective spectral suppression in pulsed field stimulation
US5374283A (en) 1993-12-01 1994-12-20 Flick; A. Bart Electrical therapeutic apparatus
US6356555B1 (en) * 1995-08-25 2002-03-12 Terayon Communications Systems, Inc. Apparatus and method for digital data transmission using orthogonal codes
US5743844A (en) 1996-11-01 1998-04-28 Amei Technologies, Inc. High efficiency pulsed electromagnetic field (PEMF) stimulation therapy method and system
US6132362A (en) 1996-11-01 2000-10-17 Amei Technologies, Inc. Pulsed electromagnetic field (PEMF) stimulation therapy system with bi-phasic coil
US6261221B1 (en) 1996-11-01 2001-07-17 Amei Technologies Inc. Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
US5968527A (en) 1997-02-27 1999-10-19 Catholic University Of America, The Protection of living systems from the adverse effects of stress
US6083149A (en) 1997-10-22 2000-07-04 Emf Therapeutics, Inc. Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals
US6186940B1 (en) 1998-05-18 2001-02-13 Robert N. Kirschbaum Energized trace elements
US6292699B1 (en) 1999-01-29 2001-09-18 Electro-Biology, Inc. Direct current stimulation of spinal interbody fixation device
CA2335966A1 (en) 1999-04-29 2000-11-09 North Shore Long Island Jewish Research Corporation Method for inducing growth and enhancing survival of nervous tissue
DE19933719A1 (de) 1999-07-19 2001-01-25 Medigene Ag Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7429471B2 (en) 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7022506B2 (en) 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US7465546B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7130692B2 (en) 2000-02-23 2006-10-31 The Trustees Of The University Of Pennsylvania Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint
US6919205B2 (en) 2000-02-23 2005-07-19 The Trustees Of The University Of Pennsylvania Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
US6485963B1 (en) 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002227147A1 (en) 2000-11-02 2002-05-15 Keith L March Method and system for modulation of oscillating signals to enhance biologic effects
US6485113B2 (en) 2001-03-08 2002-11-26 Delphi Technologies, Inc. Haptic braking method and system
WO2003004092A2 (en) 2001-07-03 2003-01-16 The Trustees Of The University Of Pennsylvania Device and method for electrically inducing osteogenesis in the spine
AU2002329223B2 (en) 2001-12-21 2007-11-22 The Trustees Of The University Of Pennsylvania Device for treating osteoporosis, hip and spine fractures and fusions with electric fields
US6955642B1 (en) 2002-11-26 2005-10-18 Ebi, Lp Pulsed electromagnetic field stimulation method and apparatus with improved dosing
US7215995B2 (en) 2003-11-14 2007-05-08 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis and cartilage disease, defects, and injuries in the human hip
JP4801802B2 (ja) 2004-01-12 2011-10-26 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 特定の選択的な電気信号および電磁信号によって生成される電場の印加を介して骨細胞における骨形成タンパク質(bmp)遺伝子発現を上方制御するシステムおよび方法

Also Published As

Publication number Publication date
KR20060024797A (ko) 2006-03-17
US7429471B2 (en) 2008-09-30
NO20060193L (no) 2006-03-06
CN1822807A (zh) 2006-08-23
KR100856964B1 (ko) 2008-09-04
EG24170A (en) 2008-09-14
WO2004112708A2 (en) 2004-12-29
EP1643953A4 (en) 2008-11-05
EP1643953A2 (en) 2006-04-12
JP2007502693A (ja) 2007-02-15
MXPA05013493A (es) 2007-03-15
AU2004249202A1 (en) 2004-12-29
IL172508A0 (en) 2006-04-10
CA2529374A1 (en) 2004-12-29
WO2004112708A3 (en) 2005-02-24
CA2529374C (en) 2010-01-26
US20040138709A1 (en) 2004-07-15
CR8145A (es) 2006-07-14

Similar Documents

Publication Publication Date Title
BRPI0411369A (pt) regulagem da expressão gênica da matriz metaloproteinase usando sinais elétricos e eletromagnéticos especìficos e seletivos
BR0315241A (pt) Método para melhorar especifica e seletivamente a expressão de gene de mrna de colágeno do tipo ii em tecido de cartilagem, dispositivo e métodos de tratamento de pelo menos uma de osteoartrite, artrite reumatóide, lesão e imperfeições de cartilagem
BRPI0506826A (pt) métodos para melhorar especìfica e seletivamente a expressão de gene de proteìna(s) morfogenéticas ósseas no tecido, dispositivo e métodos de tratamento e método para se determinar um sinal seletivo que gera um campo elétrico
Xiao et al. Facilitating protein expression with portable 5′-UTR secondary structures in Bacillus licheniformis
WO2004029210A3 (en) Resolution of aggrecan gene expression using specific and selective electrical and electromagnetic signals
Boretti The transformative potential of AI-driven CRISPR-Cas9 genome editing to enhance CAR T-cell therapy
Roth et al. Precision epigenetic editing: Technological advances, enduring challenges, and therapeutic applications
Tompkins Discovering DNA methylation, the history and future of the writing on DNA
Vassalli et al. Translational control: awakening dormant mRNAs
Yoon et al. Precise base editing without unintended indels in human cells and mouse primary myoblasts
BR112021020406A2 (pt) Sistemas de edição de genes para modificar um gene scn9a ou scn10a e métodos de uso dos mesmos
BR9811096A (pt) Sequências, moléculas, vetores e vacinas de dna recombinante para doença do calcivìrus felino e processo para a produção e o uso dos mesmos
Murphy et al. Paleo-oscillomics: inferring aspects of Neanderthal language abilities from gene regulation of neural oscillations
ATE495255T1 (de) Identifikation des gens das zum schorfigen phenotyp der maus führt, sowie seines menschlichen orthologs
Elison et al. Scarless genome editing: progress towards understanding genotype–phenotype relationships
High The moving finger
Franco et al. An investigation on genomic repeats
Sohail Gene silencing by RNA interference: technology and application
BR9709700A (pt) Vetor viral célula composição farmacêtica processo de preparação in situ de moléculas de dna circulares replicativas utilização de um vetor viral processo paa a transferência de ácidos nucleícos para uma e molécula de dna circular replicativa
Somasagara et al. Non-Viral Cell Engineering and Gene Delivery Optimization from Discovery to Clinical Applications Across Broad Cell Types
Doherty Stimulating excitable cells with optosomes: development of a non-viral cell derived vesicle capable of stimulating excitable cells in response to light stimulus.
Lu et al. CRISPR screen: a high-throughput approach for cancer genetic research.
Temiakov et al. Probing the organization of transcription complexes using photoreactive 4-thio-substituted analogs of uracil and thymidine
Melnekoff et al. Single-cell RNA sequencing reveals distinct transcriptomic profiles of multiple myeloma with implications for personalized medicine
Cao A commentary of “Novel approaches in precise genome manipulations from single nucleotides to large DNA segments”: Top 10 Scientific Advances of 2023, China

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.